Cumberland Pharmaceuticals (NASDAQ:CPIX) Now Covered by Analysts at StockNews.com

StockNews.com began coverage on shares of Cumberland Pharmaceuticals (NASDAQ:CPIXGet Rating) in a research note published on Monday. The brokerage issued a hold rating on the specialty pharmaceutical company’s stock.

Cumberland Pharmaceuticals Stock Up 1.3 %

Shares of NASDAQ:CPIX opened at $2.30 on Monday. Cumberland Pharmaceuticals has a 52-week low of $1.89 and a 52-week high of $7.51. The stock has a market cap of $33.72 million, a P/E ratio of -4.89 and a beta of 0.28. The business’s 50 day moving average is $2.41 and its 200 day moving average is $2.29. The company has a quick ratio of 1.52, a current ratio of 1.94 and a debt-to-equity ratio of 0.46.

Institutional Trading of Cumberland Pharmaceuticals

A number of hedge funds have recently bought and sold shares of CPIX. M Holdings Securities Inc. purchased a new stake in Cumberland Pharmaceuticals during the first quarter worth $30,000. Acadian Asset Management LLC lifted its holdings in Cumberland Pharmaceuticals by 27.8% during the first quarter. Acadian Asset Management LLC now owns 188,243 shares of the specialty pharmaceutical company’s stock worth $529,000 after buying an additional 40,949 shares during the period. Finally, Renaissance Technologies LLC lifted its holdings in Cumberland Pharmaceuticals by 6.3% during the first quarter. Renaissance Technologies LLC now owns 644,763 shares of the specialty pharmaceutical company’s stock worth $1,818,000 after buying an additional 38,100 shares during the period. Hedge funds and other institutional investors own 18.48% of the company’s stock.

About Cumberland Pharmaceuticals

(Get Rating)

Cumberland Pharmaceuticals Inc, a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, rheumatology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of chronic and acute constipation; Omeclamox-Pak for the treatment of Helicobacter pylori infection and duodenal ulcer disease; Vaprisol, an injection for treating euvolemic and hypervolemic hyponatremia; and Vibativ, an injection for the treatment of certain serious bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections.

Further Reading

Receive News & Ratings for Cumberland Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cumberland Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.